FRANKFURT (dpa-AFX) - Evotec extended its losses on Tuesday afternoon. It slipped 10 percent to bring up the rear of the MDax. However, stock market traders initially saw this as nothing more than a normal correction following the significant price rise at the end of last week.
In any case, the chart picture for the shares is rather unexciting. The drug discovery company's shares have been trending sideways for a year now. The company is undergoing a strategic realignment with a significant streamlining of its project portfolio./ajx/he
